Author
Listed:
- Junchao Dong
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
- Rohit A. Panchakshari
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
- Tingting Zhang
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School
† Present addresses: Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, New York 10016, USA (T.Z.); National Institute of Biological Sciences, Beijing 102206, Beijing, China (Y.Z.); Cold Spring Harbor Laboratory, Watson School of Biological Sciences, Cold Spring Harbor, New York 11724, USA (Y.-J.H.); 121Bio, 700 Main Street, Cambridge, Massachusetts 02139, USA (M.G.).)
- Yu Zhang
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School
† Present addresses: Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, New York 10016, USA (T.Z.); National Institute of Biological Sciences, Beijing 102206, Beijing, China (Y.Z.); Cold Spring Harbor Laboratory, Watson School of Biological Sciences, Cold Spring Harbor, New York 11724, USA (Y.-J.H.); 121Bio, 700 Main Street, Cambridge, Massachusetts 02139, USA (M.G.).)
- Jiazhi Hu
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
- Sabrina A. Volpi
(Boston Children’s Hospital and Joint Program in Transfusion Medicine, Harvard Medical School)
- Robin M. Meyers
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
- Yu-Jui Ho
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School
† Present addresses: Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, New York 10016, USA (T.Z.); National Institute of Biological Sciences, Beijing 102206, Beijing, China (Y.Z.); Cold Spring Harbor Laboratory, Watson School of Biological Sciences, Cold Spring Harbor, New York 11724, USA (Y.-J.H.); 121Bio, 700 Main Street, Cambridge, Massachusetts 02139, USA (M.G.).)
- Zhou Du
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
- Davide F. Robbiani
(Howard Hughes Medical Institute, Laboratory of Molecular Immunology, The Rockefeller University)
- Feilong Meng
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
- Monica Gostissa
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School
† Present addresses: Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, New York 10016, USA (T.Z.); National Institute of Biological Sciences, Beijing 102206, Beijing, China (Y.Z.); Cold Spring Harbor Laboratory, Watson School of Biological Sciences, Cold Spring Harbor, New York 11724, USA (Y.-J.H.); 121Bio, 700 Main Street, Cambridge, Massachusetts 02139, USA (M.G.).)
- Michel C. Nussenzweig
(Howard Hughes Medical Institute, Laboratory of Molecular Immunology, The Rockefeller University)
- John P. Manis
(Boston Children’s Hospital and Joint Program in Transfusion Medicine, Harvard Medical School)
- Frederick W. Alt
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
Abstract
High-throughput genome-wide sequencing reveals why class switch recombination in the IgH locus, an essential step in the process of antibody generation, has a directional joining bias towards deletion rather than inversion.
Suggested Citation
Junchao Dong & Rohit A. Panchakshari & Tingting Zhang & Yu Zhang & Jiazhi Hu & Sabrina A. Volpi & Robin M. Meyers & Yu-Jui Ho & Zhou Du & Davide F. Robbiani & Feilong Meng & Monica Gostissa & Michel C, 2015.
"Orientation-specific joining of AID-initiated DNA breaks promotes antibody class switching,"
Nature, Nature, vol. 525(7567), pages 134-139, September.
Handle:
RePEc:nat:nature:v:525:y:2015:i:7567:d:10.1038_nature14970
DOI: 10.1038/nature14970
Download full text from publisher
As the access to this document is restricted, you may want to
for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:525:y:2015:i:7567:d:10.1038_nature14970. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.